Screen to Save: NCI Colorectal Cancer Outreach & Screening Initiative
- Conditions
- Colorectal Cancer
- Registration Number
- NCT05064410
- Brief Summary
The purpose of this study is to provide educational materials and information regarding colorectal cancer (CRC), CRC screenings, and United States Preventive Services Task Force's (USPSTF) screening recommendations. USPSTF recommends screening for colorectal cancer starting at age 45 years and continuing until age 75 years.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 188
- Between 45 and 75 years of age
- Spanish or English speaking
- Able to provide informed consent
- Reside in the Tampa Bay area (namely Hillsborough, Pinellas, Polk or Pasco county)
- Does not meet inclusion criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change in Knowledge Related to Colorectal Cancer Risk, Prevention, and Screening Baseline, immediately following intervention, at 3 months and at 6 months Pre and post assessment surveys completed by participants will consist of 14 questions assessing knowledge of CRC, risk factors, and screening options and recommendations. Assessments also include 5 questions to determine intentions to change screening/health behaviors, speaking to one's healthcare provider about screening, getting screened, and talking with family/friends about CRC and CRC screening.
3-month follow up survey consists of 5 sections to determine CRC knowledge, screening behavior since baseline, future screening plans, talking with family and friends about CRC screening, and behavior changes in eating habits and physical activity since partaking in the educational session.
6-month survey consists of 5 questions about screening since the 3-month follow up survey. Those needing to complete the 6-month follow up survey are those that were screened at the time of the 3-month follow-up but had not received final diagnostic results.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Moffitt Cancer Center
🇺🇸Tampa, Florida, United States
Moffitt Cancer Center🇺🇸Tampa, Florida, United States